Sandford Sommer joins Vernalis as President & Chief Operating Officer

9-May-2016

Prior to joining the UK firm Sommer spent 24 years at AstraZeneca

Vernalis has hired Sandford (Sandy) Sommer as President & Chief Operating Officer.

Prior to joining the UK-based drug developer, Sommer spent 24 years at AstraZeneca, holding increasingly senior roles in sales and marketing, and general management. Most recently he was President of AstraZeneca┬┤s Colombia operations. Prior to this, he held a variety of leadership roles, including Global Vice President of CNS, Infection and Flu Vaccines. In the US he was Executive Director for the Seroquel franchise. He has extensive experience building brands and has been instrumental in the success of Seroquel, Nexium, and Symbicort.

Sign up for your free email newsletter

Sommer has been on the Board of the UK Colombia Trade organisation for the last two years. He began his career with sales and management positions at Astra/Merck.

Companies